CLEVELAND, June 13, 2017 /PRNewswire/ -- ViewRay, Inc.
(NASDAQ: VRAY) announced today that Chris
Raanes, Chief Executive Officer is scheduled to present at
The JMP Securities Life Sciences Conference in New York, NY.
|
Event:
|
The JMP Securities
Life Sciences Conference
|
|
|
Date:
|
Tuesday, June
20
|
|
|
Time:
|
2:00pm ET
|
|
An audio webcast of the Company's presentation will be available
on the investor relations section of ViewRay's website at
www.viewray.com. A replay of the webcast will be available for
90 days after the date of the presentation.
About ViewRay
ViewRay®, Inc. (Nasdaq: VRAY) designs,
manufactures and markets the MRIdian® radiation therapy system.
MRIdian integrates MRI technology, radiation delivery and
proprietary software to locate, target and track the position and
shape of soft-tissue tumors during radiation. ViewRay believes this
combination of enhanced visualization and accuracy will
significantly improve outcomes for patients.
ViewRay and MRIdian are registered trademarks of ViewRay,
Inc.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/viewray-to-present-at-the-jmp-securities-life-sciences-conference-300471036.html
SOURCE ViewRay, Inc.